Jinghai J. Xu

3.6k total citations · 1 hit paper
23 papers, 1.8k citations indexed

About

Jinghai J. Xu is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Jinghai J. Xu has authored 23 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Molecular Biology and 8 papers in Computational Theory and Mathematics. Recurrent topics in Jinghai J. Xu's work include Drug-Induced Hepatotoxicity and Protection (9 papers), Computational Drug Discovery Methods (8 papers) and Drug Transport and Resistance Mechanisms (6 papers). Jinghai J. Xu is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (9 papers), Computational Drug Discovery Methods (8 papers) and Drug Transport and Resistance Mechanisms (6 papers). Jinghai J. Xu collaborates with scholars based in United States, United Kingdom and Belgium. Jinghai J. Xu's co-authors include Arthur R. Smith, David de Graaf, Scott Campbell, Peter Henstock, J Chabot, Dolores Diaz, Peter J. O’Brien, Sonia M. de Morais, Sean Ekins and Steven M. Winter and has published in prestigious journals such as Biochemistry, FEBS Letters and Sensors.

In The Last Decade

Jinghai J. Xu

22 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury

2008 378 citations Jinghai J. Xu, Peter Henstock et al. Toxicological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jinghai J. Xu United States	14	715	548	416	388	230	23	1.8k
Michael D. Aleo United States	24	769 1.1×	694 1.3×	309 0.7×	343 0.9×	206 0.9×	51	2.0k
Chuang Lu United States	23	1.1k 1.5×	659 1.2×	748 1.8×	305 0.8×	139 0.6×	56	2.3k
Donald Tweedie United States	24	834 1.2×	499 0.9×	568 1.4×	158 0.4×	134 0.6×	49	1.6k
Hayley S. Brown United Kingdom	12	772 1.1×	295 0.5×	478 1.1×	194 0.5×	219 1.0×	18	1.3k
David Hallifax United Kingdom	21	1.2k 1.6×	349 0.6×	809 1.9×	271 0.7×	266 1.2×	31	1.8k
Dermot F. McGinnity United Kingdom	23	1.1k 1.5×	693 1.3×	801 1.9×	352 0.9×	81 0.4×	41	2.1k
Martin K. Bayliss United Kingdom	18	613 0.9×	344 0.6×	414 1.0×	203 0.5×	75 0.3×	32	1.4k
Michael Sinz United States	29	1.6k 2.3×	636 1.2×	1.1k 2.5×	303 0.8×	216 0.9×	72	2.8k
Deborah A. Nicoll‐Griffith Canada	26	1.2k 1.7×	1.1k 2.0×	519 1.2×	335 0.9×	122 0.5×	60	3.1k
A. David Rodrigues United States	26	924 1.3×	416 0.8×	772 1.9×	155 0.4×	117 0.5×	49	1.8k

Countries citing papers authored by Jinghai J. Xu

Since Specialization

Citations

This map shows the geographic impact of Jinghai J. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinghai J. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinghai J. Xu more than expected).

Fields of papers citing papers by Jinghai J. Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinghai J. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinghai J. Xu. The network helps show where Jinghai J. Xu may publish in the future.

Co-authorship network of co-authors of Jinghai J. Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinghai J. Xu. A scholar is included among the top collaborators of Jinghai J. Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinghai J. Xu. Jinghai J. Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Mei‐Ping, Mei‐Ping Chang, Man Kit Chang, et al.. (2016). Developing timely insights into comparative effectiveness research with a text-mining pipeline. Drug Discovery Today. 21(3). 473–480. 15 indexed citations

McEntire, Robin, James A. Butler, Mei‐Ping Chang, et al.. (2016). Application of an automated natural language processing (NLP) workflow to enable federated search of external biomedical content in drug discovery and development. Drug Discovery Today. 21(5). 826–835. 12 indexed citations

Xu, Jinghai J.. (2015). Cellular imaging: a key phenotypic screening strategy for predictive toxicology. Frontiers in Pharmacology. 6. 191–191. 3 indexed citations

Hill, Adrian, Natalie Mesens, Margino Steemans, Jinghai J. Xu, & Michael D. Aleo. (2012). Comparisons betweenin vitrowhole cell imaging andin vivozebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development. Drug Metabolism Reviews. 44(1). 127–140. 88 indexed citations

Xu, Jinghai J., et al.. (2011). Assessment of Hepatotoxicity Potential of Drug Candidate Molecules Including Kinase Inhibitors by Hepatocyte Imaging Assay Technology and Bile Flux Imaging Assay Technology. Methods in molecular biology. 795. 83–107. 12 indexed citations

Ekins, Sean, Antony Williams, & Jinghai J. Xu. (2010). A Predictive Ligand-Based Bayesian Model for Human Drug-Induced Liver Injury. Drug Metabolism and Disposition. 38(12). 2302–2308. 93 indexed citations

Ekins, Sean & Jinghai J. Xu. (2009). Drug efficacy, safety, and biologics discovery : emerging technologies and tools. John Wiley & Sons eBooks. 14 indexed citations

Feng, Bo, Jinghai J. Xu, Yi‐An Bi, et al.. (2009). Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714. Toxicological Sciences. 108(2). 492–500. 56 indexed citations

Campbell, Scott, et al.. (2009). Interaction of porphyrins with human organic anion transporting polypeptide 1B1. Chemico-Biological Interactions. 182(1). 45–51. 9 indexed citations

10.

Cosgrove, Benjamin D., Bracken M. King, Leonidas G. Alexopoulos, et al.. (2009). Synergistic drug–cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. Toxicology and Applied Pharmacology. 237(3). 317–330. 109 indexed citations

11.

Xu, Jinghai J., et al.. (2009). “Seeing is Believing”: Perspectives of Applying Imaging Technology in Discovery Toxicology. Combinatorial Chemistry & High Throughput Screening. 12(9). 827–837. 1 indexed citations

12.

Dykens, James A., Joseph Jamieson, Lisa D. Marroquin, et al.. (2008). In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone. Toxicological Sciences. 103(2). 335–345. 149 indexed citations

13.

Xu, Jinghai J., et al.. (2008). Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury. Toxicological Sciences. 105(1). 97–105. 378 indexed citations breakdown →

14.

Xu, Jinghai J., Bart S. Hendriks, Jie Zhao, & David de Graaf. (2008). Multiple effects of acetaminophen and p38 inhibitors: Towards pathway toxicology. FEBS Letters. 582(8). 1276–1282. 75 indexed citations

15.

Chen, Cuiping, et al.. (2004). DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1. Drug Metabolism and Disposition. 33(4). 537–546. 182 indexed citations

16.

Campbell, Scott, Sonia M. de Morais, & Jinghai J. Xu. (2004). Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia. Chemico-Biological Interactions. 150(2). 179–187. 113 indexed citations

17.

Xu, Jinghai J., Dolores Diaz, & Peter J. O’Brien. (2004). Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. Chemico-Biological Interactions. 150(1). 115–128. 173 indexed citations

18.

Lin, Jing, et al.. (2003). The Role of Absorption, Distribution, Metabolism, Excretion and Toxicity in Drug Discovery. Current Topics in Medicinal Chemistry. 3(10). 1125–1154. 221 indexed citations

19.

Xu, Jinghai J., et al.. (1999). Modulation of Enediyne-Induced DNA Damage by Chromatin Structures in Transcriptionally Active Genes. Biochemistry. 38(47). 15641–15646. 5 indexed citations

20.

Dedon, Peter C., et al.. (1993). Exclusive production of bistranded DNA damage by calicheamicin. Biochemistry. 32(14). 3617–3622. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact